Linezolid-Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice
Abstract Background and Objective Oral linezolid is often used as alternative therapy for intravenous vancomycin. According to the current guidelines, no dose adjustment has to be made in case of renal impairment. Nevertheless, in our hospital we have seen several patients with renal impairment who...
Saved in:
Main Authors: | S. R. E. Laarhuis (Author), C. H. M. Kerskes (Author), M. R. Nijziel (Author), R. J. A. van Wensen (Author), D. J. Touw (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
by: Hitoshi Kawasuji, et al.
Published: (2021) -
Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients
by: Hitoshi Kawasuji, et al.
Published: (2021) -
Prediction of risk factors for linezolid-induced thrombocytopenia based on neural network model
by: Xian Zhao, et al.
Published: (2024) -
Linezolid-induced ringed sideroblastic anemia and thrombocytopenia in a child with extensively drug-resistant tuberculosis
by: Snigdha Sippy, et al.
Published: (2021) -
A Regression Model to Predict Linezolid Induced Thrombocytopenia in Neonatal Sepsis Patients: A Ten-Year Retrospective Cohort Study
by: Lufen Duan, et al.
Published: (2022)